Multiple endocrine neoplasia 1 is an autosomal dominant disorder caused by mutations of the MEN1 gene.
2. |
Rochelle JM et al. (1992) A linkage map of mouse chromosome 19: definition of comparative mapping relationships with human chromosomes 10 and 11 including the MEN1 locus. |
3. |
Simonds WF et al. (2004) Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome. |
4. |
Bear JC et al. (1985) Variant multiple endocrine neoplasia I (MEN IBurin): further studies and non-linkage to HLA. |
5. |
Farid NR et al. (1980) Prolactinomas in familial multiple endocrine neoplasia syndrome type I. Relationship to HLA and carcinoid tumors. |
6. |
Chandrasekharappa SC et al. (1997) Positional cloning of the gene for multiple endocrine neoplasia-type 1. |
7. |
Agarwal SK et al. (1997) Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. |
8. |
Lemmens I et al. (1997) Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. |
9. |
Darling TN et al. (1997) Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1. |
10. |
Heppner C et al. (1997) Somatic mutation of the MEN1 gene in parathyroid tumours. |
11. |
Bassett JH et al. (1998) Characterization of mutations in patients with multiple endocrine neoplasia type 1. |
12. |
Guru SC et al. (1998) Menin, the product of the MEN1 gene, is a nuclear protein. |
13. |
Vortmeyer AO et al. (1998) Multiple endocrine neoplasia 1 gene alterations in MEN1-associated and sporadic lipomas. |
14. |
Prezant TR et al. (1998) Molecular characterization of the men1 tumor suppressor gene in sporadic pituitary tumors. |
15. |
Olufemi SE et al. (1998) Common ancestral mutation in the MEN1 gene is likely responsible for the prolactinoma variant of MEN1 (MEN1Burin) in four kindreds from Newfoundland. |
16. |
Giraud S et al. (1998) Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders. |
17. |
Teh BT et al. (1998) Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism. |
18. |
Farnebo F et al. (1998) Alterations of the MEN1 gene in sporadic parathyroid tumors. |
19. |
Carling T et al. (1998) Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism. |
20. |
Fujimori M et al. (1998) Novel V184E MEN1 germline mutation in a Japanese kindred with familial hyperparathyroidism. |
21. |
Heppner C et al. (1999) MEN1 gene analysis in sporadic adrenocortical neoplasms. |
22. |
Kjellman M et al. (1999) Genotyping of adrenocortical tumors: very frequent deletions of the MEN1 locus in 11q13 and of a 1-centimorgan region in 2p16. |
24. |
Cebrián A et al. (1999) Genetic and clinical analysis in 10 Spanish patients with multiple endocrine neoplasia type 1. |
25. |
Tahara H et al. (2000) Rare somatic inactivation of the multiple endocrine neoplasia type 1 gene in secondary hyperparathyroidism of uremia. |
26. |
Crabtree JS et al. (2001) A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. |
27. |
Pannett AA et al. (2001) Somatic mutations in MEN type 1 tumors, consistent with the Knudson "two-hit" hypothesis. |
28. |
Guo SS et al. (2001) Molecular and genetic mechanisms of tumorigenesis in multiple endocrine neoplasia type-1. |
30. |
Turner JJ et al. (2002) Frequent occurrence of an intron 4 mutation in multiple endocrine neoplasia type 1. |
31. |
Wautot V et al. (2002) Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein. |
32. |
Okamoto H et al. (2002) A novel six-nucleotide insertion in exon 4 of the MEN1 gene, 878insCTGCAG, in three patients with familial insulinoma and primary hyperparathyroidism. |
33. |
Park JH et al. (2003) Germline mutations of the MEN1 gene in Korean families with multiple endocrine neoplasia type 1 (MEN1) or MEN1-related disorders. |
34. |
Ebeling T et al. (2004) Effect of multiple endocrine neoplasia type 1 (MEN1) gene mutations on premature mortality in familial MEN1 syndrome with founder mutations. |
35. |
Busygina V et al. (2004) Hypermutability in a Drosophila model for multiple endocrine neoplasia type 1. |
36. |
Farnebo F et al. (1999) Alternative genetic pathways in parathyroid tumorigenesis. |
37. |
CUTLER RE et al. (1964) FAMILIAL HYPERPARATHYROIDISM. A KINDRED INVOLVING ELEVEN CASES, WITH A DISCUSSION OF PRIMARY CHIEF-CELL HYPERPLASIA. |
38. |
Warner J et al. (2004) Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications. |
39. |
Mallette LE et al. (1974) Parathyroid carcinoma in familial hyperparathyroidism. |
40. |
Tanaka C et al. (1998) Absence of germ-line mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in familial pituitary adenoma in contrast to MEN1 in Japanese. |
41. |
None (1976) Multiple endocrine adenomatosis syndromes. |
42. |
McCarthy DM et al. (1977) H2-Histamine receptor blocking agents in the Zollinger-Ellison syndrome. Experience in seven cases and implications for long-term therapy. |
43. |
Lamers CB et al. (1978) Prevalence of endocrine abnormalities in patients with the Zollinger-Ellison syndrome and in their families. |
44. |
Lamers CB et al. (1979) Clinical significance of hyperparathyroidism in familial multiple endocrine adenomatosis type I (MEA I). |
45. |
Prosser PR et al. (1979) Prolactin-secreting pituitary adenomas in multiple endocrine adenomatosis, type I. |
46. |
Stadil F et al. (1976) Treatment of Zollinger-Ellison syndrome with streptozotocin. |
47. |
Straus E et al. (1977) Canine Zollinger-Ellison syndrome. |
48. |
Tateishi R et al. (1978) Coexistence of bilateral pheochromocytoma and pancreatic islet cell tumor: report of a case and review of the literature. |
49. |
Regan PT et al. (1978) A reappraisal of clinical, roentgenographic, and endoscopic features of the Zollinger-Ellison syndrome. |
50. |
Deveney CW et al. (1978) The Zollinger-Ellison syndrome--23 years later. |
51. |
Cocco AE et al. (1975) Zollinger-Ellison syndrome associated with ovarian mucinous cystadenocarcinoma. |
52. |
Larsson C et al. (1992) Predictive testing for multiple endocrine neoplasia type 1 using DNA polymorphisms. |
53. |
Sawicki MP et al. (1992) Loss of heterozygosity on chromosome 11 in sporadic gastrinomas. |
54. |
Skogseid B et al. (1992) Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. |
55. |
Richard CW et al. (1991) A radiation hybrid map of the proximal long arm of human chromosome 11 containing the multiple endocrine neoplasia type 1 (MEN-1) and bcl-1 disease loci. |
56. |
Fujimori M et al. (1992) Fine-scale mapping of the gene responsible for multiple endocrine neoplasia type 1 (MEN 1). |
57. |
Byström C et al. (1990) Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. |
58. |
Nakamura Y et al. (1989) Localization of the genetic defect in multiple endocrine neoplasia type 1 within a small region of chromosome 11. |
59. |
Bale SJ et al. (1989) Linkage analysis of multiple endocrine neoplasia type 1 with INT2 and other markers on chromosome 11. |
60. |
Friedman E et al. (1989) Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. |
61. |
Thakker RV et al. (1989) Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. |
62. |
Brandi ML et al. (1986) Parathyroid mitogenic activity in plasma from patients with familial multiple endocrine neoplasia type 1. |
63. |
None (1986) Multiple endocrine neoplasia: search for the oncogenic trigger. |
64. |
Maton PN et al. (1986) Cushing's syndrome in patients with the Zollinger-Ellison syndrome. |
65. |
Bahn RS et al. (1986) Nonidentical expressions of multiple endocrine neoplasia, type I, in identical twins. |
66. |
Larsson C et al. (1988) Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. |
67. |
Chedid A et al. (1988) Hereditary pituitary prolactinomas: a new rat model. |
68. |
Wolfe MM et al. (1987) Zollinger-Ellison syndrome. Current concepts in diagnosis and management. |
69. |
Guida PM et al. (1966) Zollinger-Ellison syndrome with interesting variations. Report of twelve cases including one of carcinoid of the duodenum. |
70. |
Jones BS et al. (1970) A case of the Zollinger-Ellison syndrome associated with hyperplasia of salivary and Brunner's glands. |
71. |
Friesen SR et al. (1972) Genetic aspects of the Z-E syndrome: prospective studies in two kindred; antral gastrin cell hyperplasia. |
72. |
Johnson GJ et al. (1967) Clinical and genetic investigation of a large kindred with multiple endocrine adenomatosis. |
73. |
Lulu DJ et al. (1968) Familial endocrine adenomatosis with associated Zollinger-Ellison syndrome. Wermer's syndrome. |
74. |
Way L et al. (1968) Zollinger-Ellison syndrome. An analysis of twenty-five cases. |
75. |
Vance JE et al. (1969) Nesidioblastosis in familial endocrine adenomatosis. |
76. |
Vance JE et al. (1972) Familial nesidioblastosis as the predominant manifestation of multiple endocrine adenomatosis. |
77. |
Snyder N et al. (1972) Five families with multiple endocrine adenomatosis. |
78. |
Ellison EH et al. (1967) The Zollinger-Ellison syndrome updated. |
79. |
Buchta RM et al. (1971) Zollinger-Ellison syndrome in a nine-year-old child: a case report and review of the entity in childhood. |
80. |
Betts JB et al. (1980) Hyperparathyroidism: a prerequisite for Zollinger-Ellison syndrome in multiple endocrine adenomatosis Type 1--report of a further family and a review of th literature. |
81. |
Reimer D et al. (1981) A kindred with 5 cases of multiple endocrine adenomatosis type I. |
82. |
Stacpoole PW et al. (1981) A familial glucagonoma syndrome: genetic, clinical and biochemical features. |
83. |
Mee AS et al. (1983) Changing concepts in the presentation, diagnosis and management of the Zollinger-Ellison syndrome. |
84. |
None (1984) Genetic aspects of multiple endocrine neoplasia. |
85. |
Hershon KS et al. (1983) Prolactinomas as part of the multiple endocrine neoplastic syndrome type 1. |
86. |
None (1982) Zollinger-Ellison syndrome. |
87. |
Long TT et al. (1980) Conservative management of the Zollinger-Ellison syndrome. Ectopic gastrin production by an ovarian cystadenoma. |
88. |
Petty EM et al. (1994) Mapping the gene for hereditary hyperparathyroidism and prolactinoma (MEN1Burin) to chromosome 11q: evidence for a founder effect in patients from Newfoundland. |
89. |
Gaitan D et al. (1993) Two patients with Cushing's disease in a kindred with multiple endocrine neoplasia type I. |
90. |
Guru SC et al. (1997) A transcript map for the 2.8-Mb region containing the multiple endocrine neoplasia type 1 locus. |
91. |
Lemmens I et al. (1997) Construction of a 1.2-Mb sequence-ready contig of chromosome 11q13 encompassing the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. |
92. |
None (1998) Multiple endocrine neoplasia--syndromes of the twentieth century. |
93. |
Sato M et al. (1998) Identification of five novel germline mutations of the MEN1 gene in Japanese multiple endocrine neoplasia type 1 (MEN1) families. |
94. |
Yu F et al. (1999) Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome. |
95. |
Guru SC et al. (1999) Isolation, genomic organization, and expression analysis of Men1, the murine homolog of the MEN1 gene. |
96. |
Hessman O et al. (2001) Multiple allelic deletions and intratumoral genetic heterogeneity in men1 pancreatic tumors. |
97. |
Schussheim DH et al. () Multiple endocrine neoplasia type 1: new clinical and basic findings. |
98. |
Bordi C et al. (2001) The antral mucosa as a new site for endocrine tumors in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndromes. |
99. |
Brandi ML et al. (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. |
100. |
Vergès B et al. (2002) Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study. |
101. |
None (1954) Genetic aspects of adenomatosis of endocrine glands. |
102. |
ZOLLINGER RM et al. (1955) Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas. |
103. |
WILLIAMS ED et al. (1962) The association of bronchial carcinoid and pluriglandular adenomatosis. |
104. |
UNDERWOOD LE et al. (1963) FAMILIAL ENDOCRINE ADENOMATOSIS. A FAMILY WITH HYPERINSULINISM AS THE PREDOMINANT MANIFESTATION. |
105. |
BALLARD HS et al. (1964) FAMILIAL MULTIPLE ENDOCRINE ADENOMA-PEPTIC ULCER COMPLEX. |
106. |
ELLISON EH et al. (1964) THE ZOLLINGER-ELLISON SYNDROME: RE-APPRAISAL AND EVALUATION OF 260 REGISTERED CASES. |
107. |
Hao W et al. (2004) Multiple endocrine neoplasia type 1 variant with frequent prolactinoma and rare gastrinoma. |
109. |
Scacheri PC et al. (2004) Homozygous loss of menin is well tolerated in liver, a tissue not affected in MEN1. |
110. |
Perren A et al. (2007) Multiple endocrine neoplasia type 1 (MEN1): loss of one MEN1 allele in tumors and monohormonal endocrine cell clusters but not in islet hyperplasia of the pancreas. |
111. |
Lemos MC et al. (2008) Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. |